XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS
All marketable securities were classified as available-for-sale at September 30, 2022 and December 31, 2021.
The following tables show the Company’s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:
September 30, 2022
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Aggregate Fair ValueCash and Cash Equivalents
Short-term
Marketable
Securities (1)
Long-term
Marketable
Securities (2)
Level 1:
Cash$358,325 $— $— $358,325 $358,325 $— $— 
Level 2:
Money market instruments347,274 — — 347,274 347,274 — — 
Corporate debt securities522,723 10 (14,622)508,111 978 273,333 233,800 
U.S. government agency securities354,810 (4,377)350,437 54,938 209,469 86,030 
Commercial paper29,461 (22)29,440 — 29,440 — 
Asset-backed securities53,182 — (699)52,483 — 11 52,472 
Subtotal1,307,450 15 (19,720)1,287,745 403,190 512,253 372,302 
Total$1,665,775 $15 $(19,720)$1,646,070 $761,515 $512,253 $372,302 
December 31, 2021
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Aggregate Fair ValueCash and Cash Equivalents
Short-term
Marketable
Securities (1)
Long-term
Marketable
Securities (2)
Level 1:
Cash$301,177 $— $— $301,177 $301,177 $— $— 
Level 2:
Money market instruments285,099 — — 285,099 285,099 — — 
Corporate debt securities584,000 386 (2,086)582,300 — 200,304 381,996 
U.S. government agency securities224,774 182 (325)224,631 — 146,421 78,210 
Commercial paper68,384 — — 68,384 1,000 67,384 — 
Asset-backed securities56,936 10 (95)56,851 — 9,451 47,400 
Foreign and other3,097 141 (12)3,226 — 3,039 187 
Subtotal1,222,290 719 (2,518)1,220,491 286,099 426,599 507,793 
Total$1,523,467 $719 $(2,518)$1,521,668 $587,276 $426,599 $507,793 
(1)    The Company’s short-term marketable securities mature in one year or less.
(2)    The Company’s long-term marketable securities mature between one and five years.
As of September 30, 2022, the Company had the ability and intent to hold all investments that were in an unrealized loss position until maturity. The Company considered its intent and ability to hold the securities until recovery of amortized cost basis, the extent to which fair value is less than amortized cost basis, conditions specifically related to the security’s industry and geography, payment structure and history and changes to the ratings (if any) in determining that the decline in fair value compared to carrying value is not related to a credit loss.
The Company has certain investments in non-marketable equity securities, measured using unobservable valuation inputs and remeasured on a nonrecurring basis, which are collectively considered strategic investments. As of September 30, 2022 and December 31, 2021, the fair value of the Company’s strategic investments was $23.7 million and $16.5 million, respectively. These investments were recorded in Other Assets in the Company’s Condensed Consolidated Balance Sheets.